Shinji Fukuda, Ph.D.
Senior Scientific Advisor
Dr. Fukuda specializes in environment control for intestinal microbiota. After receiving his Ph.D. in Agricultural Science, he completed his Special Postdoctoral Researcher in fundamental sciences at RIKEN Research Institute in Japan. From 2012-2019, Dr. Fukuda was specially appointed associate professor at Keio University, Institute for Advanced Biosciences.
In 2015, he established Metabologenomics, Inc. as President and CEO. Most recently in 2020, Dr. Fukuda co-founded Metagen Therapeutics Inc.
